Combined 12-month analysis of ILLUMENATE EU and US trials presented at LINC 2017

599

At LINC 2017 (24–27 January, Leipzig, Germany), Sean Lyden (Cleveland Clinic, Cleveland, USA) presented an update on the 12-month results of the European and US cohorts of the ILLUMENATE randomised controlled trials, which are investigating the use of the Stellarex (Spectranetics) drug-coated balloon to treat peripheral arterial disease. Vascular News caught up with Lyden after his presentation, to hear the highlight results and their significance.